Published in Clin Exp Rheumatol on July 08, 2003
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med (2007) 2.69
We need better classification and terminology for "people at high risk of or in the process of developing lupus". Arthritis Care Res (Hoboken) (2015) 1.51
Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol (2009) 1.30
Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol (2009) 1.19
Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther (2008) 1.19
Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung (2010) 1.11
Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population. J Rheumatol (2008) 0.85
Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease. J Bras Pneumol (2014) 0.82
Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year. Rheumatol Int (2011) 0.82
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature. Diagn Pathol (2011) 0.80
Preclinical systemic lupus erythematosus. Rheum Dis Clin North Am (2014) 0.79
Reliability and validity of the Italian version of the Chronic Pain Grade questionnaire in patients with musculoskeletal disorders. Clin Rheumatol (2006) 0.78
Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center. Clin Rheumatol (2015) 0.76
An unusual case of undifferentiated connective tissue disease presenting as cardiac tamponade. Rheumatol Int (2009) 0.76
Undifferentiated vasculitis or an evolving systemic autoimmune rheumatic disease? Oxf Med Case Reports (2016) 0.75
Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Curr Opin Rheumatol (2016) 0.75
Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Relat Outcome Meas (2017) 0.75
Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report. BMC Musculoskelet Disord (2015) 0.75
The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. Open Rheumatol J (2016) 0.75
Undifferentiated connective tissue diseases-related hepatic injury. World J Gastroenterol (2008) 0.75
[Early symptoms of dermatomyositis and antisynthetase syndrome]. Z Rheumatol (2013) 0.75
[Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems]. Z Rheumatol (2013) 0.75
The composite genome of the legume symbiont Sinorhizobium meliloti. Science (2001) 9.11
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021. Proc Natl Acad Sci U S A (2001) 2.83
The mitotic inhibitor ccs52 is required for endoreduplication and ploidy-dependent cell enlargement in plants. EMBO J (1999) 2.40
Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) (2005) 1.81
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
Effect of caffeine on intramembrane charge movement and calcium transients in cut skeletal muscle fibres of the frog. J Physiol (1983) 1.68
Blocking of indium incorporation by antimony in III-V-Sb nanostructures. Nanotechnology (2010) 1.62
Calcium-activated chloride channels in bovine pulmonary artery endothelial cells. J Physiol (1997) 1.55
Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature (1976) 1.54
PM-SCL autoantibody positive scleroderma with polymyositis (mechanic's hand: clinical aid in the diagnosis). J Eur Acad Dermatol Venereol (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Activation of viruses in human tumors by 5-iododeoxyuridine and dimethyl sulfoxide. Science (1972) 1.48
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual. Lupus (2007) 1.46
Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1982) 1.44
Blockers of volume-activated Cl- currents inhibit endothelial cell proliferation. Pflugers Arch (1995) 1.42
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
[Favorable in vitro effect of pentoxifylline on damaged lymphocyte migration in arteriosclerosis obliterans and systemic lupus erythematosus]. Orv Hetil (1993) 1.39
[Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"]. Orv Hetil (1998) 1.38
Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol Pharmacol (1966) 1.36
Novel rkp gene clusters of Sinorhizobium meliloti involved in capsular polysaccharide production and invasion of the symbiotic nodule: the rkpK gene encodes a UDP-glucose dehydrogenase. J Bacteriol (1998) 1.32
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology (1993) 1.30
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol (1989) 1.25
Sequence heterogeneity among human picobirnaviruses detected in a gastroenteritis outbreak. Arch Virol (2003) 1.25
The complex role of vitamin D in autoimmune diseases. Scand J Immunol (2008) 1.25
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J Immunol (1999) 1.18
Analysis of the oral manifestations of systemic sclerosis. Oral Surg Oral Med Oral Pathol (1994) 1.17
Perchlorate and the relationship between charge movement and contractile activation in frog skeletal muscle fibres. J Physiol (1987) 1.17
Comparison of birefringence signals and calcium transients in voltage-clamped cut skeletal muscle fibres of the frog. J Physiol (1983) 1.16
Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis (2007) 1.16
Selective ion-induced intermixing and damage in low-dimensional GaN/AlN quantum structures. Nanotechnology (2013) 1.15
Retinoic acid-induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase. J Biol Chem (1985) 1.13
Lymphocyte surface immunoglobulins in autoimmune diseases. Lancet (1973) 1.11
Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) (2006) 1.11
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) (2001) 1.10
In situ detection of hepatitis A virus in cell cultures and shellfish tissues. Appl Environ Microbiol (1994) 1.09
Persistently infected cultures as a source of hepatitis A virus. Appl Environ Microbiol (1985) 1.08
Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses. J Public Health (Oxf) (2007) 1.08
Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome. Clin Exp Immunol (2009) 1.07
Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry (2005) 1.07
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) (1999) 1.06
Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun (1980) 1.06
Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med (1998) 1.06
Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) (2004) 1.05
Annexin II modulates volume-activated chloride currents in vascular endothelial cells. J Biol Chem (1996) 1.02
Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects. Acta Microbiol Acad Sci Hung (1967) 1.02
Determination of the strain generated in InAs/InP quantum wires: prediction of nucleation sites. Nanotechnology (2006) 1.02
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. Rheumatology (Oxford) (2007) 1.02
Antiphospholipid antibodies in acute coronary syndrome. Lupus (2004) 1.00
Study of the subunit interactions in myosin phosphatase by surface plasmon resonance. Eur J Biochem (2000) 1.00
A new giant pterosaur with a robust skull from the latest cretaceous of Romania. Naturwissenschaften (2002) 1.00
Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Clin Exp Immunol (1999) 1.00
Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis (2007) 1.00
Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate. Cancer Res (1976) 0.99
Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus (2007) 0.99
Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE. J Immunol Methods (1982) 0.99
Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol (2009) 0.98
Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritic patients. Clin Nephrol (1984) 0.98
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus (2010) 0.98
Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol (1999) 0.97
Factor XIII of blood coagulation in human monocytes. Thromb Res (1985) 0.97
T and B lymphocytes in pregnancy. Klin Wochenschr (1974) 0.97
The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol (2010) 0.97
TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol (2006) 0.96
Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines. Ann N Y Acad Sci (1981) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Differential distribution of TASK-1, TASK-2 and TASK-3 immunoreactivities in the rat and human cerebellum. Cell Mol Life Sci (2004) 0.96
Endogenous lipoid pneumonia associated with undifferentiated connective tissue disease (UCTD). Med Sci Monit (2001) 0.95
Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) (2008) 0.95
Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. Clin Exp Rheumatol (2008) 0.95
Localized scleroderma after exposure to organic solvents. Dermatology (1994) 0.95
Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant (2007) 0.94
Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment Pharmacol Ther (2006) 0.94
Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. J Investig Med (1996) 0.93
Phospholamban ablation and compensatory responses in the mammalian heart. Ann N Y Acad Sci (1998) 0.93
The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells. Carcinogenesis (1983) 0.93
Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol (2004) 0.93
Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum (1996) 0.93
Survival analysis of 118 patients with systemic sclerosis. J Intern Med (1993) 0.93
Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor. Proc Natl Acad Sci U S A (1977) 0.92
Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary. Scand J Immunol (2006) 0.92